Clay B. Siegall, is the President, Chief Executive Officer and Chairman of the Board of Seattle genetics and one of the founders of the company. The scientist has acquired a Ph.D. in Genetics from George Washington University and a Bachelors degree in Zoology from the University of Maryland.
Dr.B.Siegall has experienced training in targeted cancer therapies. Dr. Siegall came up with Seattle Genetics and grew on a foundation that the scientific innovation, research, and drug development practices are put in place to a goal of helping patients. He has generated the antibody-drug conjugates (ADCs) for the treatment of cancer.
By this tremendous leadership of Dr. Clay Siegall, Seattle Genetics has got various strategic licenses for its Antibody Drug Conjugates Technology, including some of which Genentech (Roche), AbbVie, GlaxoSmithKline and Pfizer are involved.
Historical career background of Dr. Clay Siegall
Dr. Siegall was among the Bristol-Myers Squibb Pharmaceutical Research Institute department as a Senior Research involved in investigation afterward he served as a Principal Scientist from 1995-1997. He was then the Chairman of Seattle Genetics, Inc. approximately in 2004.
He has been the Director and leader of Seattle Genetics Inc. since 1997. He worked also as a Director of Washington Biotechnology and Biomedical Association (WBBA) and furthermore as a Non-Executive Director of Mirna Therapeutics, Inc. In his recent achievements, he is a member who is counseling for the Cancer Treatment Research Foundation in a board.
In his great legacy, he was given several awards that include the Pierce Award for his research on the field of targeted toxins; he was also the Ernst & Young Pacific Northwest Entrepreneur of the Year award finalist of the categorized healthcare.
Dr.Clay Siegall explained of a possible treatment of cancer that he believes that the old-guard of cancer treatment, could be the systemic chemotherapies: he further believes that the therapies of old will be supplanted by the far more tolerable and vastly more effective targeted drugs. His hard work in selling drugs to patients and giving them hope is what makes him successful in his personal life and business.A famous and popular kind.